Analytical Data
-
Gene name
MUSTN1
- Application
-
Alternative Names
MUSTN1;Musculoskeletal embryonic nuclear Protein 1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8IVN3
-
Expression Region
1-82aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSMSQAGAQ EAPIKKKRPP VKEEDLKGAR GNLTKNQEIK SKTYQVMREC EQAGSAAPSV FSRTRTGTET VFEKPKAGPT KSVFG
-
Molecular Weight
11 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MUSTN1, or MUST domain-containing protein 1, is a relatively newly discovered gene that plays a significant role in various physiological and pathological processes, including cell proliferation, differentiation, and apoptosis. Research indicates that MUSTN1 is implicated in tumorigenesis, particularly in certain types of cancers, by influencing the cell cycle and promoting oncogenic pathways. Its expression has been shown to be upregulated in several tumor tissues, suggesting its potential as a biomarker for cancer diagnosis and a target for therapeutic interventions. Moreover, MUSTN1's involvement in immune responses and developmental processes has garnered interest from researchers aiming to elucidate its functional mechanisms. The need for further understanding of its structure and interactions has led to the production of recombinant MUSTN1 protein for biochemical and biophysical studies. By analyzing this protein, scientists hope to uncover its precise roles in cellular signaling and its potential interactions with other proteins, contributing to the broader understanding of cancer biology and providing insights that may lead to novel treatment strategies. Consequently, the study of recombinant MUSTN1 protein serves as a crucial step toward unraveling its multifaceted functions and expanding the therapeutic landscape for cancer and other diseases associated with its dysregulation.
